J&J Innovation taps Texas for its latest biotech startup incubator

Johnson & Johnson ($JNJ) is taking its network of biopharma incubators to Texas in an expansion of its Janssen Labs initiative. To be located at Houston's Texas Medical Center, the incubator hopes to foster as many as 50 local biotech startups. Report

Suggested Articles

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan

Pfizer struck a deal to produce Gilead Sciences' remdesivir, which has been running short at some hard-hit U.S. hospitals.

AZ licenses COVID-19 vaccine to BioKangtai in China. Pfizer and BioNTech will supply 120 million doses of their shot to Japan. Legend CEO resigned.